ea0019p18 | Bone | SFEBES2009
Panteliou E
Objectives: To compare the diabetic (DM) (n=124) and non diabetic (nonDM) (n=63) patients on haemodialysis (HD) in terms of renal bone disease (RBD) control.Methods: Retrospective case-note review of 187 HD patients. The National Kidney Foundation guidelines for chronic kidney disease stage 5 (CKD-5) were used, with target levels for parathormone (PTH) 16.533 pmol/l, calcium 2.12.35 mmols/l and phosphate 1.78 mmols/l.<p clas...